CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hynynen, M.
Right arrow Articles by Rosenberg, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hynynen, M.
Right arrow Articles by Rosenberg, P. H.

Canadian Journal of Anesthesia, Vol 41, 583-588, Copyright © 1994 by Canadian Anesthesiologists' Society

ARTICLES

Propofol sequestration within the extracorporeal circuit

M Hynynen, E Hammaren and PH Rosenberg
Department of Anaesthesia, Helsinki University Central Hospital, Finland.

Various drugs administered during cardiac anaesthesia are sequestered in the extracorporeal circuit in vitro, but it is uncertain whether this sequestration phenomenon affects plasma drug concentration in vivo. The present study was undertaken to evaluate (1) in vitro sequestration of propofol in the extracorporeal circuit and (2) whether the change in plasma propofol concentration induced by initiation of cardiopulmonary bypass in vivo can be explained by haemodilution. For the in vitro evaluation, three separate experiments with a closed circuit (membrane oxygenator, reservoir, and tubings) were performed. The pH and PCO2 of the circulating solution (a mixture of Ringer's acetate and whole blood) were maintained within the normal physiological range, and the temperature of the solution was 28 degrees C. The solution was circulated at a flow of 4 L.min-1 and propofol was added to the solution to achieve a concentration of 2 micrograms.ml-1. Serial samples were taken from the circulating solution for measurement of propofol concentration by high performance liquid chromatography. In the in vivo part of the study, 14 patients received a continuous infusion of propofol, and samples for the determination of plasma propofol concentration and blood haematocrit were taken before and five and ten minutes after initiation of cardiopulmonary bypass. In vitro, at 5 and 120 min after addition of propofol into the circulating solution, approximately 65% and 25%, respectively, of the predicted propofol level was measurable in the solution.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
J. Ahonen, A. Sahlman, A. Yli-Hankala, H. Eriksson, A. Nemlander, J. Ramo, and M. Salmenpera
No effect of cardiopulmonary bypass on hypnosis in patients anaesthetized with propofol and alfentanil
Br. J. Anaesth., January 1, 2004; 92(1): 137 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
K. Yoshitani, M. Kawaguchi, M. Takahashi, K. Kitaguchi, and H. Furuya
Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass
Br. J. Anaesth., February 1, 2003; 90(2): 122 - 126.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Canadian Anesthesiologists' Society.